Autopsy report · NCT00311987

Study of 3,5-Diiodothyropropionic Acid (DITPA) in Hypercholesterolemic Patients

“Curtailment of funding by sponsor”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year before it stopped.
• 60 participants planned (an estimate, not an actual count).
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1, Phase 2

Sponsor

Johns Hopkins University

Sponsor type

University, hospital or other

Conditions

Hypercholesterolemia

Interventions

3,5-Diiodothyropropionic acid (DITPA) therapy

Participants

60 (planned, not actual)

Sites

1

Countries

United States

Trials that died the same way

• MISP 60528 Pneumococcal Vaccination
  “Termination of funding by the sponsor/funder.” (85% match in meaning)
• Safety and Efficacy of ABI-009 (Nab-rapamycin) in Combination With Pomalidomide and Dexamethasone for Relapsed and Refractory Multiple Myeloma
  “Funding withdrawn by sponsor” (82% match in meaning)
• ACTHAR Gel for Drug REsistant Nephrotic Syndrome in Children
  “Withdrawal of funding from primary sponsor” (81% match in meaning)
• 129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study
  “Sponsor withdrew Funding” (79% match in meaning)
• A Study of Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung Cancer
  “Sponsor decision - funding issues” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.